Literature DB >> 36253507

Identification of Potential Megalin/Cubilin Substrates Using Extensive Proteomics Quantification from Kidney Megalin-Knockdown Mice.

Bei Zhao1, Chengjian Tu1,2, Shichen Shen1,2, Jun Qu1,2, Marilyn E Morris3.   

Abstract

Megalin and cubilin, endocytic proteins present in the proximal tubule of the kidney, are responsible for reabsorbing filtered proteins from urine. Our hypothesis was that potential substrates of megalin/cubilin could be identified by examining urinary protein differences between control (WT) mice and kidney-specific megalin knockdown (KD) mice. Using the IonStar proteomics approach, 877 potential megalin/cubilin substrates were discovered, with 23 of these compounds representing known megalin/cubilin substrates. Some of the proteins with the largest fold changes in the urine between KD and WT included the known megalin substrates retinol-binding protein and vitamin D-binding protein. Of the total proteins identified as novel substrates, about three-quarters of compounds had molecular weights (MWs) below 69 kDa, the MW of albumin, and the remaining had higher MWs, with about 5% of the proteins having MWs greater than 150 kDa. Sex differences in the number of identified substrates occurred, but this may be due to differences in kidney megalin expression between both male and female megalin KD and WT animals, with the ratio of megalin between WT and KD being 2.76 and 2.14 for female and male mice, respectively. The top three ingenuity canonical pathways based on the urinary proteins in both female and male KD mice were acute phase response signaling, liver X receptor/retinoid X receptor activation, and intrinsic prothrombin activation pathways. In conclusion, analysis of urine samples from kidney-specific megalin KD and WT mice was found to be useful for the identification of potential endogenous substrates for megalin and cubilin.
© 2022. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  Endogenous proteins; Kidney reabsorption; LC–MS/MS; Megalin/cubilin; Receptor-mediated endocytosis

Mesh:

Substances:

Year:  2022        PMID: 36253507     DOI: 10.1208/s12248-022-00758-2

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   3.603


  43 in total

Review 1.  Megalin and cubilin in proximal tubule protein reabsorption: from experimental models to human disease.

Authors:  Rikke Nielsen; Erik Ilsø Christensen; Henrik Birn
Journal:  Kidney Int       Date:  2016-01       Impact factor: 10.612

2.  Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3).

Authors:  A Nykjaer; J C Fyfe; R Kozyraki; J R Leheste; C Jacobsen; M S Nielsen; P J Verroust; M Aminoff; A de la Chapelle; S K Moestrup; R Ray; J Gliemann; T E Willnow; E I Christensen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 3.  Targeting strategies for drug delivery to the kidney: From renal glomeruli to tubules.

Authors:  Chun-Ping Liu; You Hu; Ju-Chun Lin; Hua-Lin Fu; Lee Yong Lim; Zhi-Xiang Yuan
Journal:  Med Res Rev       Date:  2018-08-22       Impact factor: 12.944

4.  Evidence for the role of megalin in renal uptake of transthyretin.

Authors:  M M Sousa; A G Norden; C Jacobsen; T E Willnow; E I Christensen; R V Thakker; P J Verroust; S K Moestrup; M J Saraiva
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

5.  Megalin binds and internalizes angiotensin-(1-7).

Authors:  Romer Gonzalez-Villalobos; R Bryan Klassen; Patricia L Allen; Kelly Johanson; Chasity B Baker; Hiroyuki Kobori; L G Navar; Timothy G Hammond
Journal:  Am J Physiol Renal Physiol       Date:  2005-12-27

6.  Megalin acts in concert with cubilin to mediate endocytosis of high density lipoproteins.

Authors:  S M Hammad; J L Barth; C Knaak; W S Argraves
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

7.  Megalin knockout mice as an animal model of low molecular weight proteinuria.

Authors:  J R Leheste; B Rolinski; H Vorum; J Hilpert; A Nykjaer; C Jacobsen; P Aucouturier; J O Moskaug; A Otto; E I Christensen; T E Willnow
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

8.  Megalin binds and internalizes angiotensin II.

Authors:  Romer Gonzalez-Villalobos; R Bryan Klassen; Patricia L Allen; L G Navar; Timothy G Hammond
Journal:  Am J Physiol Renal Physiol       Date:  2004-10-05

9.  Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity.

Authors:  Yoshihisa Hori; Nobumasa Aoki; Shoji Kuwahara; Michihiro Hosojima; Ryohei Kaseda; Sawako Goto; Tomomichi Iida; Shankhajit De; Hideyuki Kabasawa; Reika Kaneko; Hiroyuki Aoki; Yoshinari Tanabe; Hiroshi Kagamu; Ichiei Narita; Toshiaki Kikuchi; Akihiko Saito
Journal:  J Am Soc Nephrol       Date:  2017-01-04       Impact factor: 10.121

Review 10.  Nephrotoxicity of recent anti-cancer agents.

Authors:  Norbert Lameire
Journal:  Clin Kidney J       Date:  2013-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.